Corporate R&D investments following competitors' voluntary disclosures : evidence from the drug development process
Year of publication: |
2024
|
---|---|
Authors: | Zhang, Yue |
Published in: |
Journal of accounting research. - Oxford [u.a.] : Wiley-Blackwell, ISSN 1475-679X, ZDB-ID 2060654-0. - Vol. 62.2024, 1, p. 335-373
|
Subject: | deterrence | disclosure externalities | drug development | innovation | peer effects | proprietary cost | R&D competition | Unternehmenspublizität | Corporate disclosure | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Wettbewerb | Competition | Pharmakologie | Pharmacology | Innovation |
-
Banerjee, Tannista, (2014)
-
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona, (2017)
-
The risk of innovation : measuring drug clinical development in Brazil
Rocha, Michele de Medeiros, (2018)
- More ...
-
Safety Analysis and Strategy of Alipay
Yuan, Chong, (2016)
-
Design of Ultrasonic Oil Tank Level System
Zhang, Yue, (2017)
-
Hong, Paul, (2018)
- More ...